ITINERIS – Trademark Portfolio
Entity Type: 32
ITINERIS holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include UMAX, ITINERIS, and ITINERIS EXCELLENCE IN UTILITIES.
B-9051 Gent
Kortrijksesteenweg 1144
Showing of trademarks Trademarks
Trademark Classifications
ITINERIS's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does ITINERIS have?
ITINERIS has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.
What trademark classes does ITINERIS file in?
ITINERIS files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are ITINERIS's most well-known trademarks?
ITINERIS's registered trademark portfolio includes well-known marks such as UMAX, ITINERIS, and ITINERIS EXCELLENCE IN UTILITIES. These are among 3 currently registered trademarks in the portfolio.
What is ITINERIS's trademark registration success rate?
ITINERIS has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.